Predictors of Major Cardiac Events in the Late Follow-Up in Patients Treated With PTCA During Q Wave AMI
|
|
- Chad Cox
- 5 years ago
- Views:
Transcription
1 Home SVCC Area: English - Español - Português Predictors of Major Cardiac Events in the Late Follow-Up in Patients Treated With PTCA During Q Wave AMI Torresani, E.M.; Weisshein, N.; Martino, G.; Hrabar, A.; Fernández A.; Bujan, L.; De Benedetti, L.; Alvarez, C.; Cohen, M.; Leguizamón, J.H. Dpto de Cardiología, Sanatorio Modelo Quilmes, Buenos Aires, Argentina SUMMARY Background: The objective of the present study is to analyze Clinical and/or Angiographic predictors of combined Major Adverse Cardiac Events (MACE) [Death (D), Heart Failure (HF), Myocardial Revascularization (MR), new Q wave AMI, Post AMI Angina (PIA)]in the follow-up of patients (pts) treated with PTCA in Q wave AMI. Methods: From 8/94 until 8/99 we carried out 135 PTCA in the course of an AMI [Primary (PA): 84 pts, Rescue (RA): 51 pts] with a Primary Success of 90.3% and an In-Hospital mortality of 11.1% (15/135). A mean follow-up of 28.2 months (1 to 64 months) was obtained in the remaining 120 pts. Results: During the first month the incidence of MACE was 14.1% due to MR for Multivessel Disease (MVD) 10 pts, PIA 4 pts and HF 3 pts. In the long term evolution the rate of MACE was 18.3% due to MR 7 pts, D 7 pts and HF 8 pts. With Kaplan Meier curves it was observed that the survival rate was 95% at one year, without necessity of MR in 80% and event free survival in 70 %. Weren t predictors of MACE the Risk Factors, PA or RA, previous AMI, lesion length, angled, ostial or bifurcational lesions, tortuous access, reference diameter, neither the use of Stent. The univariate analysis showed that there was greater incidence of MACE in pts with MVD [1vessel:17/74 (22.9%), MVD:20/46 (43.4%)-p<0.031], inferior AMI [Anterior: 18/64 (28.1%), Inferior: 16/35 (45.7%), Other: 3/21 (14.2%)- p<0.037] and calcified lesions [Ca+ yes:14/28 (50%), Ca+ no: 23/92 (25%)- p<0.023]. Multivariate analysis showed that age (Odds Ratio: 1.06-p<0.005), male gender (Odds Ratio: 3.7-p<0.049), delayed time to admission (Odds Ratio:0.82-p<0.022), calcification (Odds Ratio:3.09-p<0.015) and PTCA Failures (Odds Ratio:12.7-p<0.0008) were predictors of MACE. Conclusions: 1) Age, gender, MVD, calcified lesions and delayed time to admission were independent predictors of MACE. 2) Those pts with PTCA failures had greater incidence of MACE. 3) Pts with inferior AMI had an augmented incidence of MACE; more analysis should be made in this sense. Top INTRODUCTION The AMI is secondary to arterial occlusion for rupture of the atheroesclerotic plaque (1). The reperfusion therapy with trombolytics drugs has been very effective in these patients (2-5) although with a medium index of repermeabilization of the culprit vessel. The Transluminal Coronary Angioplasty has demonstrated to be the best treatment to restore the flow in the artery as much primary like rescue angioplasty (6-11). The rate of immediate success of these patients is high (6-13);however some of them evolve so much in the intra-hospital phase like in the follow-up with heart events that influences in its quality of life and costs of health. The objective of the present study is to analyze possible clinical and/or angiographics predictors of combined major cardiac events (death, heart failure, post AMI angina, new AMI, myocardial revascularization ) in the follow-up of patients treated with PTCA in Q wave AMI. MATERIAL AND METHOD From August of 1994 to August of 1999, were admitted 239 patients with a transmural AMI with less than 12 hours of evolution of which 135 were derived for the realization of PTCA [84 pts to primary PTCA (35.1%) and 51 pts to rescue PTCA (32.9%)] being achieved a primary success of 90.3% (122/135) with an intra-hospital mortality of 11.1% (15/135). A mean follow-up of 28.2 month (1 to 64 month)was obtained in the remaining 120 pts. Definition of primary success: It was considered primary success a residual obstruction < 30% with TIMI 3 flow and without major complications.
2 Definition of failure: The failure was defined as the impossibility of achieving primary success for difficulty in to cross or to dilate the obstruction appropriately or not to achieve TIMI 3 flow in absence of complications. Definition of major complication: Death, emergency surgical revascularization or worsening of the clinical picture (Killip-Kimbal to class 3-4). Combined Major Cardiac Events (MACE): Death, heart failure, post AMI angina, new AMI, myocardial revascularization. Statistical analysis: The continuous variables are expressed as half ± 1 SD and the qualitative ones as proportions. The proportions were analyzed by means of determination of differences among standard error. The Student's test was used to compare 2 stockings, and the Chi square to compare proportions (the Fisher correction was used when it was necessary). Were also used the Walk's test, Mann - Whitney's test and multivariate analysis for logistical regression with multiple regression coefficient for event yes / no, determining the statistical significance (p < 0.05). The survival free of events in the pursuit was considered by means of the method of Kaplan-Meier. RESULTS During the first month the incidence of MACE was of 14.1% (17/120) being secondary to myocardial revascularization necessity(tlr) for multiple vessel disease in 10 pts, post AMI angina in 4 pts and heart failure in 3 pts. In the far follow-up the rate of MACE was of 18.3%: myocardial revascularization in 7 pts, 7 deaths and 8 pts with heart failure. By Kaplan - Meier's analysis we observe that the survival freedom of MACE was 95% in the first year without necessity of TLR in 80% and free of MACE in a 70%. (Figure 1) There were not predictors of MACE the risk factors (tobacco, diabetes, hipercholesterolemia, hypertension), primary or rescue PTCA, previous AMI, lesion length, angle, ostium or bifurcation localization, tortuous access, reference diameter, neither use of Stent. (Table 1, 2, 3)
3
4 The univariate analysis showed that there was bigger incidence of MACE in pts with multiple vessel disease, inferior localization and calcification. (Table 3) In the multivariate analysis for logistical regression we observe that the age, the male gender, the evolution's time of the AMI, the presence of calcification and the PTCA failures were predictors of MACE. (Table 4) DISCUSSION The benefits of the mechanical reperfusion by the angioplasty have been outstanding from their beginnings (14-15) so much when it is direct as of rescue (6-12), but we know that a percentage of these patients evolves with MACE that reduces the initial success. Several papers have followed the clinical evolution trying to determine which are the probable predictors of these events (13). Our results show that the clinical /angiographics characteristics in the studied population is comparable with the literature (6-13,17-19), being the primary success similar to that of other registers, as much in direct PTCA as of rescue. It is interesting to stress that the MACE post AMI was observed fundamentally during the first year of follow-up being arrived to a stability plateau in most of the cases during at least the 5 subsequent years. We have not found here to the analyzed risk factors as predictors of MACE, contrary to other studies where there was a tendency to more mortality in the diabetic patients (6, 20), there being you also observed to the female gender as event predictor in opposition with this study where by means of the multivariate analysis the predictor was the male gender. The age, multiple vessel disease and the calcified lesions are predictors of worse evolution due to more affection grade. The early admission (evolution's time of AMI) and the success of the treatment, as in other studies, demonstrated as predictors of good
5 evolution, influenced for to obtain or not TIMI 3 flow. Finally we don't have clear the reason why the pts with inferior AMI (multivariate analysis) had bigger incidence of events, we believe that more analysis should be made in this sense. CONCLUSIONS 1) Age, gender, multiple vessel disease, calcified lesions and delayed time to admission were independent predictors of MACE. 2) Those pts with PTCA failures had greater incidence of MACE. 3) Pts with inferior AMI had an augmented incidence of MACE; more analysis should be made in this sense. REFERENCES 1. Fuster V, Badimon L, Badimon JJ, et al: The pathogenesis of coronary artery disease and the acute coronary syndrome. N Engl J Med 1992; 326: , De Wood MA, Spores J, Notske R,et al: Prevalence of total coronary oclussion during the early hours of transmural myocardial infarction. N Engl J Med 3. Fibrinolytic Therapy Trialist (FTT) Collaborative Group indications for fibrinolytic therapy in suspected acute myocardial infarction: Collaborative over view of early mortality and major morbility results from all randomized trial of more than 1000 patients. Lancet 1994; 343: An international randomized trial comparating four thrombolytic strategies for acute myocardial infarctions. GUSTO trial. N Engl J Med;329: ISIS 3. A randomized comparation streptokinase vs. tissue plasminogen activator vs. anisteplase and / or aspirin alone among cases of suspected acute myocardial infarction. Lancet 1992; 339: O'Neill W, Stone G, Grines C, et al: Predictors of In-Hospital and 6-Month outcome After Acute Myocardial Infarction in the Reperfusion Era. PAMI trial. J Am Coll Cardiol 1995;25:370/7. 7. Ziljstra F, de Boer MJ, Hoorntje JCA, et al: A comparison of inmediate coronary angioplasty with intravenous streptokinase in acute myocardial infarction. N Engl J Med 1993;328: Zijlstra F, Hoorntje JCA, Boer MJ, et al. Long-term of Primary Angioplasty as Compared with Thrombolytic Therapy for Acute Myocardial Infarction. N Engl J Med 1999; 341: Weaver WD, Simes RJ, Betriú A, et al: Comparation of primary coronary angioplasty and intravenous thrombolytic therapy for acute myocardial infarction: A quantitative review. JAMA 1997;278 (23): Gibbson RJ, Holmes D, Reeder GS, et al: Inmediate angioplasty compared with the administration of a thrombolytic agent followed by conservative treatment for myocardial infarction. N Engl J Med 1993; 328: Ellis SG, Ribiero da Silva, Heyndrickx G, et al: Randomized comparation of rescue angioplasty with conservative management of patient with early failure of thrombolytic for acute anterior myocardial infarction. Circulation 1991; 90: Leguizamón JH, Nauwerk R, Torresani EM, y col. Angioplastia coronaria en 115 pacientes cursando un IAM: 4 años de experiencia. Parte 1 Angioplastia de rescate. Rev Arg de Cardiol 1991;Vol59, nº 5, TLP Ferroni F, Baratta S, Bang JH y col. CONAREC V. Rev Arg de Cardiología ; Vol 67: Grüntzig AR: Transluminal dilatation of coronary artery stenosis. Lancet 1978; 1: Hartzler GO, Ruthenford BD,, et al Early and late results of coronary angioplasty without antecedent thrombolytic therapy for acute myocardial infarction. Am J Cardiol;1989; 64: Trongé JE. Cardiología Bertolasi CA (ed) Buenos Aires, Intermédica Cap 29. Tomo 3. pag Weaver WD, Simes RJ, Betri ú A, et al. The Primary Angioplasty vs Thrombolysis Collaboration Group: Comparation of primary coronary angioplasty and intravenous thrombolytic therapy for acute myocardial infarction. A quantitative review.jama 1997; 278: TIMI II study group. Comparation of invasive and conservative strategies after treatment with intravenous tissue plasminogen activator in acute myocardial infarction. Results of the thrombolysis in Myocardial Infarction. N Engl J Med 1989;320:618.
6 19. Gruppo Italiano per lo studio della streptochinassi nello'infarto Miocardico:Long terms effects of intravenous thrombolytic in acute myocardial infarction. GISSI study. Lancet 1997; 2: Moreno R, García E, Soriano J y col. Early Coronary Angioplasty for Acute Myocardial Infarction: Predictors of a Poor Outcome Non-Selected. J Invas Cardiol 2001;13 (3): Top Your questions, contributions and commentaries will be answered by the authors in the Interventional Cardiology list. Please fill in the form (in Spanish, Portuguese or English) and press the "Send" button. Question, contribution or commentary: Name and Surname: Country: address: Send Erase Top 2nd Virtual Congress of Cardiology Dr. Florencio Garófalo Steering Committee President fgaro@fac.org.ar fgaro@satlink.com Dr. Raúl Bretal Scientific Committee President rbretal@fac.org.ar rbretal@netverk.com.ar Dr. Armando Pacher Technical Committee - CETIFAC President apacher@fac.org.ar apacher@satlink.com Copyright Argentine Federation of Cardiology All rights reserved This company contributed to the Congress:
Predictors of PTCA Failures in Q Wave AMI. Uni and Multivariate Analysis
Home SVCC Area: English - Español - Português Predictors of PTCA Failures in Q Wave AMI. Uni and Multivariate Analysis Torresani, E.M.; Weisshein, N.; Martino, G.; Hrabar, A.; Fernández, A.; Cohen M.;
More informationTobacco Consumption and Acute Myocardial Infarction
Home SVCC Area: English - Español - Português Tobacco Consumption and Acute Myocardial Infarction Bianco, Eduardo; Cobas, Joaquín Cardiac Care Unit (CCU), Asociación Española Primera de Socorros Mutuos.
More informationStent Trials in Acute Myocardial Infarction
IAGS 1998 Proceedings Stent Trials in Acute Myocardial Infarction Alfredo Rodríguez MD, PhD Primary angioplasty in the early phase of acute myocardial infarction has been demonstrated to reduce in-hospital
More informationInfluence of Treatment Delay on Infarct Size and Clinical Outcome in Patients With Acute Myocardial Infarction Treated With Primary Angioplasty
629 Influence of Treatment Delay on Infarct Size and Clinical Outcome in Patients With Acute Myocardial Infarction Treated With Primary Angioplasty AYLEE L. LIEM, MD, ARNOUD W.J. VAN T HOF, MD, JAN C.A.
More informationPrimary PCI versus thrombolytic therapy: long-term follow-up according to infarct location
Heart Online First, published on April 14, 2005 as 10.1136/hrt.2005.060152 1 Primary PCI versus thrombolytic therapy: long-term follow-up according to infarct location Short running head: Anterior infarction
More informationJournal of the American College of Cardiology Vol. 39, No. 11, by the American College of Cardiology Foundation ISSN /02/$22.
Journal of the American College of Cardiology Vol. 39, No. 11, 2002 2002 by the American College of Cardiology Foundation ISSN 0735-1097/02/$22.00 Published by Elsevier Science Inc. PII S0735-1097(02)01856-9
More informationJournal of the American College of Cardiology Vol. 35, No. 4, by the American College of Cardiology ISSN /00/$20.
Journal of the American College of Cardiology Vol. 35, No. 4, 2000 2000 by the American College of Cardiology ISSN 0735-1097/00/$20.00 Published by Elsevier Science Inc. PII S0735-1097(99)00643-9 Early
More informationHon-Kan Yip, MD; Chiung-Jen Wu, MD; Morgan Fu, MD; Kuo-Ho Yeh, MD; Teng-Hung Yu, MD; Wei-Chin Hung, MD; and Mien-Cheng Chen, MD
Clinical Features and Outcome of Patients With Direct Percutaneous Coronary Intervention for Acute Myocardial Infarction Resulting From Left Circumflex Artery Occlusion* Hon-Kan Yip, MD; Chiung-Jen Wu,
More informationA. W. J. van t Hof, A. Liem, H. Suryapranata, J. C. A. Hoorntje, M.-J de Boer and F. Zijlstra
European Heart Journal (1998) 19, 118 123 Clinical presentation and outcome of patients with early, intermediate and late reperfusion therapy by primary coronary angioplasty for acute myocardial infarction
More informationJournal of the American College of Cardiology Vol. 33, No. 3, by the American College of Cardiology ISSN /99/$20.
Journal of the American College of Cardiology Vol. 33, No. 3, 1999 1999 by the American College of Cardiology ISSN 0735-1097/99/$20.00 Published by Elsevier Science Inc. PII S0735-1097(98)00644-5 Primary
More informationSustained Benefit 20 Years After Reperfusion Therapy in Acute Myocardial Infarction
Journal of the American College of Cardiology Vol. 46, No. 1, 2005 2005 by the American College of Cardiology Foundation ISSN 0735-1097/05/$30.00 Published by Elsevier Inc. doi:10.1016/j.jacc.2005.03.047
More informationJournal of the American College of Cardiology Vol. 37, No. 6, by the American College of Cardiology ISSN /01/$20.
Journal of the American College of Cardiology Vol. 37, No. 6, 2001 2001 by the American College of Cardiology ISSN 0735-1097/01/$20.00 Published by Elsevier Science Inc. PII S0735-1097(01)01198-6 Consequences
More informationPRIMARY CORONARY ANGIOPLASTY VERSUS INTRAVENOUS THROMBOLYSIS FOR ACUTE MYOCARDIAL INFARCTION - A COMPARATIVE STUDY AT QUEEN ALIA HEART INSTITUTE
PRIMARY CORONARY ANGIOPLASTY VERSUS INTRAVENOUS THROMBOLYSIS FOR ACUTE MYOCARDIAL INFARCTION - A COMPARATIVE STUDY AT QUEEN ALIA HEART INSTITUTE Walid Sawalha MD, MBBS (Lond), MRCP(UK)* ABSTRACT Objectives:
More informationA Report From the Second National Registry of Myocardial Infarction (NRMI-2)
1240 JACC Vol. 31, No. 6 Clinical Experience With Primary Percutaneous Transluminal Coronary Angioplasty Compared With Alteplase (Recombinant Tissue-Type Plasminogen Activator) in Patients With Acute Myocardial
More informationOUTCOME OF THROMBOLYTIC AND NON- THROMBOLYTIC THERAPY IN ACUTE MYOCARDIAL INFARCTION
OUTCOME OF THROMBOLYTIC AND NON- THROMBOLYTIC THERAPY IN ACUTE MYOCARDIAL INFARCTION FEROZ MEMON*, LIAQUAT CHEEMA**, NAND LAL RATHI***, RAJ KUMAR***, NAZIR AHMED MEMON**** OBJECTIVE: To compare morbidity,
More informationEmergency physician versus cardiologistinitiated thrombolysis for acute myocardial infarction: a Singapore experience
O r i g i n a l A r t i c l e Singapore Med J 2004 Vol 45(7) : 313 Emergency physician versus cardiologistinitiated thrombolysis for acute myocardial infarction: a Singapore experience I Irwani, C M Seet,
More informationIn the treatment of acute myocardial infarction (AMI), 1 3 restoring coronary perfusion
BACK OF THE ENVELOPE DAVID M. KENT, MD JOSEPH LAU, MD HARRY P. SELKER, MD, MSPH New England Medical Center Tufts University School of Medicine Boston, Mass Eff Clin Pract. 2001;4:214-220. Balancing the
More informationCurrent Advances and Best Practices in Acute STEMI Management A pharmacoinvasive approach
Current Advances and Best Practices in Acute STEMI Management A pharmacoinvasive approach Frans Van de Werf, MD, PhD University Hospitals, Leuven, Belgium Frans Van de Werf: Disclosures Research grants
More informationThe First 12 Hours. ST-Segment Elevation AMI: Introduction. Definitions
ST-Segment Elevation AMI: The First 12 Hours Acute myocardial infarction (AMI) accounts for half of the deaths due to ischemic heart disease and is associated with significant use of resources. Because
More informationJournal of the American College of Cardiology Vol. 33, No. 2, by the American College of Cardiology ISSN /99/$20.
Journal of the American College of Cardiology Vol. 33, No. 2, 1999 1999 by the American College of Cardiology ISSN 0735-1097/99/$20.00 Published by Elsevier Science Inc. PII S0735-1097(98)00579-8 Effect
More informationDiabetic Patients: Current Evidence of Revascularization
Diabetic Patients: Current Evidence of Revascularization Alexandra J. Lansky, MD Yale University School of Medicine University College of London The Problem with Diabetic Patients Endothelial dysfunction
More informationPreprocedural TIMI Flow and Mortality in Patients With Acute Myocardial Infarction Treated by Primary Angioplasty
Journal of the American College of Cardiology Vol. 43, No. 8, 2004 2004 by the American College of Cardiology Foundation ISSN 0735-1097/04/$30.00 Published by Elsevier Inc. doi:10.1016/j.jacc.2003.11.042
More informationFibrinolytic Therapy Past, Present, and Future
Home SVCC Area: English - Español - Português Fibrinolytic Therapy Past, Present, and Future John M. Field, MD Division of Cardiology, Hershey Medical Center, Penn State University College of Medicine,
More informationAn Open Randomized Study Prague-5 ˆ
Next Day Discharge After Successful Primary Angioplasty for Acute ST Elevation Myocardial Infarction An Open Randomized Study Prague-5 Radovan JIRMÁR, 1 MD, Petr WIDIMSKÝ, 1 MD, Jan CAPEK, 1 MD, Ota HLINOMAZ,
More informationDirect percutaneous transluminal coronary angioplasty in acute myocardial infarction
European Heart Journal (1998) 19, 917-921 Direct percutaneous transluminal coronary angioplasty in acute myocardial infarction Predictors of short-term outcome and the impact of coronary stenting A. Vogt*,
More informationDrug Therapy: Fixed Combinations in Antihypertensive Treatment
Home SVCC Area: English - Español - Português Drug Therapy: Fixed Combinations in Antihypertensive Treatment Alberto Villamil, MD Hypertension Department, ICBA and Dr. Cosme Argerich Hospital, Buenos Aires,
More informationCase Report Rheolytic Thrombectomy Combined with a Protective Filter and Platelet Glycoprotein IIb/IIIa Receptor Inhibitors in Rescue Angioplasty
Hell J Cardiol 46: 430-434, 2005 Case Report Rheolytic Thrombectomy Combined with a Protective Filter and Platelet Glycoprotein IIb/IIIa Receptor Inhibitors in Rescue Angioplasty PETROS S. DARDAS, NIKOS
More informationClinical Seminar. Which Diabetic Patient is a Candidate for Percutaneous Coronary Intervention - European Perspective
Clinical Seminar Which Diabetic Patient is a Candidate for Percutaneous Coronary Intervention - European Perspective Stephan Windecker Department of Cardiology Swiss Cardiovascular Center and Clinical
More informationWhat is the Optimal Triple Anti-platelet Therapy Duration in Patients with Acute Myocardial Infarction Undergoing Drug-eluting Stents Implantation?
What is the Optimal Triple Anti-platelet Therapy Duration in Patients with Acute Myocardial Infarction Undergoing Drug-eluting Stents Implantation? Keun-Ho Park, Myung Ho Jeong, Min Goo Lee, Jum Suk Ko,
More informationSide Branch Occlusion
Side Branch Occlusion Mechanism, Outcome, and How to avoid it From COBIS II Registry Hyeon-Cheol Gwon Cardiac&Vascular Center, Samsung Medical Center Sungkyunkwan University School of Medicine SB occlusion
More informationSymptom-Onset-to-Balloon Time and Mortality in Patients With Acute Myocardial Infarction Treated by Primary Angioplasty
Journal of the American College of Cardiology Vol. 42, No. 6, 2003 2003 by the American College of Cardiology Foundation ISSN 0735-1097/03/$30.00 Published by Elsevier Inc. doi:10.1016/s0735-1097(03)00919-7
More informationThe treatment of myocardial infarction
Heart 2001;85:705 709 CORONARY DISEASE Acute myocardial infarction: primary angioplasty Felix Zijlstra Department of Cardiology, Hospital De Weezenlanden, Zwolle, The Netherlands Correspondence to: Dr
More informationThrombolysis or primary angioplasty? Reperfusion therapy for myocardial infarction in the UK
1 University of Leeds Medical School, Leeds, UK; 2 Department of Cardiology, Leeds General Infirmary, Leeds, UK Correspondence to: Dr C Pepper, Department of Cardiology, Leeds General Infirmary, Leeds
More informationFacilitated Percutaneous Coronary Intervention in Acute Myocardial Infarction. Is it beneficial to patients?
Facilitated Percutaneous Coronary Intervention in Acute Myocardial Infarction Is it beneficial to patients? Seung-Jea Tahk, MD. PhD. Suwon, Korea Facilitated PCI.. background Degree of coronary flow at
More informationContemporary Percutaneous Coronary Intervention Versus Balloon Angioplasty for Multivessel Coronary Artery Disease
Contemporary Percutaneous Coronary Intervention Versus Balloon Angioplasty for Multivessel Coronary Artery Disease A Comparison of the National Heart, Lung and Blood Institute Dynamic Registry and the
More informationTime delays in instituting thrombolysis in acute myocardial infarction - a Singapore perspective
Hong Kong Journal of Emergency Medicine Time delays in instituting thrombolysis in acute myocardial infarction - a Singapore perspective M Tiru and SH Goh The reduction of mortality from acute myocardial
More informationJournal of the American College of Cardiology Vol. 33, No. 5, by the American College of Cardiology ISSN /99/$20.
Journal of the American College of Cardiology Vol. 33, No. 5, 1999 1999 by the American College of Cardiology ISSN 0735-1097/99/$20.00 Published by Elsevier Science Inc. PII S0735-1097(99)00009-1 Primary
More informationRelationship between body mass index, coronary disease extension and clinical outcomes in patients with acute coronary syndrome
Relationship between body mass index, coronary disease extension and clinical outcomes in patients with acute coronary syndrome Helder Dores, Luís Bronze Carvalho, Ingrid Rosário, Sílvio Leal, Maria João
More informationST-SEGMENT ELEVATION MYOCARDIAL INFARCTION (STEMI): DECREASING THE TIME TO TREATMENT IN THE ED
ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION (STEMI): DECREASING THE TIME TO TREATMENT IN THE ED W. Brian Gibler, MD Professor and Chairman; Department of Emergency Medicine, University of Cincinnati College
More informationPCI for Left Anterior Descending Artery Ostial Stenosis
PCI for Left Anterior Descending Artery Ostial Stenosis Why do you hesitate PCI for LAD ostial stenosis? LAD Ostial Lesion Limitations of PCI High elastic recoil Involvement of the distal left main coronary
More informationLack of progress in cardiogenic shock: lessons from the GUSTO trials
European Heart Journal (2000) 21, 1928 1936 doi:10.1053/euhj.2000.2240, available online at http://www.idealibrary.com on Lack of progress in cardiogenic shock: lessons from the GUSTO trials V. Menon 1,
More informationCulprit Lesion Remodeling and Long-term (> 5years) Prognosis in Patients with Acute Coronary Syndrome
Culprit Lesion Remodeling and Long-term (> 5years) Prognosis in Patients with Acute Coronary Syndrome Hiroyuki Okura*, MD; Nobuya Matsushita**,MD Kenji Shimeno**, MD; Hiroyuki Yamaghishi**, MD Iku Toda**,
More informationAbstract Background: Methods: Results: Conclusions:
Two-Year Clinical and Angiographic Outcomes of Overlapping Sirolimusversus Paclitaxel- Eluting Stents in the Treatment of Diffuse Long Coronary Lesions Kang-Yin Chen 1,2, Seung-Woon Rha 1, Yong-Jian Li
More informationAcute Coronary Syndrome (ACS) is the consequence of
Clinical Practice Pharmaco-invasive Therapy for STEMI; The Most Suitable STEMI Reperfusion Therapy for Transferred Patients in Thailand Pradub Sukhum, MD. 1 1 Division of Cardiovascular Medicine, Bangkok
More informationThrombolysis in acute myocardial infarction: analysis of studies comparing accelerated t-pa and streptokinase
3'Accid Emerg Med 1999;16:407-41 1 Thrombolysis in acute myocardial infarction: analysis of studies comparing accelerated t-pa and streptokinase Brendon J Smith 407 Department of Emergency Medicine, Sutherland
More informationDespite the excellent results of reperfusion therapies for
Prognostic Assessment of Patients With Acute Myocardial Infarction Treated With Primary Angioplasty Implications for Early Discharge Giuseppe De Luca, MD; Harry Suryapranata, MD, PhD; Arnoud W.J. van t
More informationHospital and 1-year outcome after acute myocardial infarction in patients with diabetes mellitus and hypertension
(2003) 17, 665 670 & 2003 Nature Publishing Group All rights reserved 0950-9240/03 $25.00 www.nature.com/jhh ORIGINAL ARTICLE Hospital and 1-year outcome after acute myocardial infarction in patients with
More informationDESolve NX Trial Clinical and Imaging Results
DESolve NX Trial Clinical and Imaging Results Alexandre Abizaid, MD, PhD, Instituto Dante Pazzanese, Sao Paulo, Brazil On behalf of the DESolve Nx Trial Investigators Please refer to the TCT2014 App or
More informationMyocardial infarction (MI) is the single largest killer of
Use of Emergency Medical Services in Acute Myocardial Infarction and Subsequent Quality of Care Observations From the National Registry of Myocardial Infarction 2 John G. Canto, MD, MSPH; Robert J. Zalenski,
More informationManagement of ST-elevation myocardial infarction Update 2009 Late comers: which options?
European Society of Cardiology Annual Session 2009 Management of ST-elevation myocardial infarction Update 2009 Late comers: which options? Antonio Abbate, MD Assistant Professor of Medicine Virginia Commonwealth
More informationEFFICACY OF THROMBOLYTIC THERAPY IN PRESERVING LEFT VENTRICULAR FUNCTION FOLLOWING ACUTE MYOCARDIAL INFARCTION
EFFICACY OF THROMBOLYTIC THERAPY IN PRESERVING LEFT VENTRICULAR FUNCTION FOLLOWING ACUTE MYOCARDIAL INFARCTION SUMMARY ABID AMIN KHAN, NOOR AHMED, MAIMOONA INAYAT This study is a prospective study to determine
More informationPrognostic Significance of Epicardial Blood Flow Before and After Percutaneous Coronary Intervention in Patients With Acute Coronary Syndromes
Journal of the American College of Cardiology Vol. 52, No. 7, 2008 2008 by the American College of Cardiology Foundation ISSN 0735-1097/08/$34.00 Published by Elsevier Inc. doi:10.1016/j.jacc.2008.05.009
More informationPatient Transfer. Mark de Belder The James Cook University Hospital Middlesbrough
Patient Transfer Mark de Belder The James Cook University Hospital Middlesbrough Current Management Strategies for ACS ACS No ST Elevation ST ST Elevation Elevation Early Invasive Early Conservative Fibrinolysis
More informationCindy L. Grines MD FACC FSCAI
Cindy L. Grines MD FACC FSCAI Hofstra Northwell School of Medicine Chair, Cardiology Academic Chief of Cardiology, Northwell Health North Shore University Hospital, Manhasset NY Multivessel Disease in
More informationPCI for Left Main Coronary Artery Stenosis. Jean Fajadet Clinique Pasteur, Toulouse, France
PCI for Left Main Coronary Artery Stenosis Jean Fajadet Clinique Pasteur, Toulouse, France Athens, October 19, 2018 Left Main Coronary Artery Disease Significant unprotected left main coronary artery disease
More informationThis House believes that experience and size is not relevant
This House believes that experience and size is not relevant Providing a primary angioplasty service Hotly debated topics Treatment of MI Stewed prunes vs warmed milk Treatment of MI early mobilisation
More informationDebate Should we use FFR? I will say NO.
Debate Should we use FFR? I will say NO. Hyeon-Cheol Gwon Cardiac and Vascular Center Samsung Medical Center Sungkyunkwan University School of Medicine Dr. Hyeon-Cheol Gwon Research fund from Abbott Korea
More informationThree-Year Clinical Outcomes with Everolimus-Eluting Bioresorbable Scaffolds: Results from the Randomized ABSORB III Trial Stephen G.
Three-Year Clinical Outcomes with Everolimus-Eluting Bioresorbable Scaffolds: Results from the Randomized ABSORB III Trial Stephen G. Ellis MD Dean J. Kereiakes MD and Gregg W. Stone MD for the ABSORB
More informationMULTIVESSEL DISEASE AS A PROGNOSTIC FACTOR FOR MORTALITY IN STEMI PATIENTS. Summary
Original Article MULTIVESSEL DISEASE AS A PROGNOSTIC FACTOR FOR MORTALITY IN STEMI PATIENTS Kiril K.Karamfiloff, Zhivka D. Stoykova, Petya G. Georeva1, Diana K. Trendafilova, Julia B. Jorgova University
More informationACUTE MYOCARDIAL INFARCtion
ORIGINAL CONTRIBUTION Primary Coronary Angioplasty vs for the Management of Acute Myocardial Infarction in Elderly Patients Alan K. Berger, MD Kevin A. Schulman, MD Bernard J. Gersh, MB, ChB, DPhil Sarmad
More informationPatient referral for elective coronary angiography: challenging the current strategy
Patient referral for elective coronary angiography: challenging the current strategy M. Santos, A. Ferreira, A. P. Sousa, J. Brito, R. Calé, L. Raposo, P. Gonçalves, R. Teles, M. Almeida, M. Mendes Cardiology
More informationFormation of and countermeasures for subacute coronary stent thrombosis in elderly diabetic patients
Formation of and countermeasures for subacute coronary stent thrombosis in elderly diabetic patients Z.-F. Li 1, Y.-P. Zhang 2, Z.-Q. Qin 2, X.-L. Li 1, C.-H. Gao 1, S. Yang 1 and Z.-J. Chen 1 1 Department
More informationFFR-guided Complete vs. Culprit Only Revascularization in AMI Patients Ki Hong Choi, MD On Behalf of FRAME-AMI Investigators
FFR-guided Complete vs. Culprit Only Revascularization in AMI Patients Ki Hong Choi, MD On Behalf of FRAME-AMI Investigators Heart Vascular Stroke Institute, Samsung Medical Center, Seoul, Republic of
More informationCardiogenic Shock. Carlos Cafri,, MD
Cardiogenic Shock Carlos Cafri,, MD SHOCK= Inadequate Tissue Mechanisms: Perfusion Inadequate oxygen delivery Release of inflammatory mediators Further microvascular changes, compromised blood flow and
More informationLM stenting - Cypher
LM stenting - Cypher Left main stenting with BMS Since 1995 Issues in BMS era AMC Restenosis and TLR (%) 3 27 TLR P=.282 Restenosis P=.71 28 2 1 15 12 Ostium 5 4 Shaft Bifurcation Left main stenting with
More informationCritical Review Form Therapy Objectives: Methods:
Critical Review Form Therapy Clinical Trial Comparing Primary Coronary Angioplasty with Tissue-Plasminogen Activator for Acute Myocardial Infarction (GUSTO-IIb), NEJM 1997; 336: 1621-1628 Objectives: To
More informationStatin pretreatment and presentation patterns in patients with acute coronary syndromes
Brief Report Page 1 of 5 Statin pretreatment and presentation patterns in patients with acute coronary syndromes Marcelo Trivi, Ruth Henquin, Juan Costabel, Diego Conde Cardiovascular Institute of Buenos
More informationFinal Clinical and Angiographic Results From a Nationwide Registry of FIREBIRD Sirolimus- Eluting Stent: Firebird In China (FIC) Registry (PI R. Gao)
The Microport FIREBIRD Polymer-based Sirolimus- Eluting Stent Clinical Trial Program Update: The FIC and FIREMAN Registries Junbo Ge, MD, FACC, FESC, FSCAI On behalf of Runlin Gao (FIC PI) and Haichang
More informationORIGINAL ARTICLE. Rescue PCI Versus a Conservative Approach for Failed Fibrinolysis in Patients with STEMI
Heart Mirror Journal From Affiliated Egyptian Universities and Cardiology Centers Vol. 6, No. 3, 2012 ISSN 1687-6652 ORIGINAL ARTICLE for Failed Fibrinolysis in Patients with STEMI Mohamed Salem, MD, PhD;
More informationWhat do the guidelines say?
Percutaneous coronary intervention in 3-vessel disease and main stem What do the guidelines say? Nothing to disclose Dariusz Dudek Institute of Cardiology, Jagiellonian University Krakow, Poland The European
More informationTHE CURRENT SITUATION AND FUTURE OF THE PERCUTANEOUS CORONARY INTERVENTION FOR ACUTE CORONARY SYNDROM IN RUSSIAN FEDERATION
: 616.127-005.8 -..,.. -...,, ( ), 2011, 581 182. 195 592 ( ) 385 590 -. 4,3 % 8,8 % ( ). 2011 62 329,, 24 931 (40 %) -. : - - ; ; 70 % ST ( ST); ST - 24. : ST,. THE CURRENT SITUATION AND FUTURE OF THE
More informationOP Chest Pain General Data Element List. All Records All Records. All Records All Records All Records. All Records. All Records.
Material inside brackets ([and]) is new to this Specifications Manual version. Hospital Outpatient Quality Measures Chest Pain (CP) Set Measure ID # OP-4 * OP-5 * Measure Short Name Aspirin at Arrival
More informationHon-Kan Yip, MD; Chiung-Jen Wu, MD; Mien-Cheng Chen, MD; Hsueh-Wen Chang, PhD; Kelvin Yuan-Kai Hsieh, MD; Chi-Ling Hang, MD; and Morgan Fu, MD
Effect of Primary Angioplasty on Total or Subtotal Left Main Occlusion* Analysis of Incidence, Clinical Features, Outcomes, and Prognostic Determinants Hon-Kan Yip, MD; Chiung-Jen Wu, MD; Mien-Cheng Chen,
More informationCoronary Plaque Sealing: The DEFER Study and more...
Coronary Plaque Sealing: The DEFER Study and more... How Waiting Can Be Beneficial in Stable Coronary Artery Disease Patients ESC, Stockholm, 2005 M. Romanens, 21.09.2005 at www.kardiolab.ch DEFER Study:
More informationPCI Strategies After Fibrinolytic Therapy
PCI Strategies After Fibrinolytic Therapy How to choose the appropriate reperfusion strategy. BY MICHEL R. LE MAY, MD Survival in patients presenting with ST-segment elevation myocardial infarction (STEMI)
More informationEndovascular beta-irradiation with a liquid 188 Re-filled balloon to reduce restenosis after coronary angioplasty.
Endovascular beta-irradiation with a liquid 188 Re-filled balloon to reduce restenosis after coronary angioplasty. Peix A., Llerena L., Ponce F., López A., López L., Guerrero I., Cabrera L.O., Maltas A.M.,
More informationPercutaneous Intervention of Unprotected Left Main Disease
Percutaneous Intervention of Unprotected Left Main Disease Technical feasibility and Clinical outcomes Seung-Jung Park, MD, PhD, FACC Professor of Internal Medicine Asan Medical Center, Seoul, Korea Unprotected
More informationJournal of the American College of Cardiology Vol. 35, No. 5, by the American College of Cardiology ISSN /00/$20.
Journal of the American College of Cardiology Vol. 35, No. 5, 2000 2000 by the American College of Cardiology ISSN 0735-1097/00/$20.00 Published by Elsevier Science Inc. PII S0735-1097(00)00546-5 CLINICAL
More informationStudy on Primary Percutaneous Coronary Intervention (PCI) in Patient with Acute Myocardial Infarction: in-hospital and 30-days Survival Outcome
Study on Primary Percutaneous Coronary Intervention (PCI) in Patient with Acute Myocardial Infarction: in-hospital and 30-days Survival Outcome AQM Reza, AHMW Islam, S Munwar, S Talukder Department of
More informationLessons learned From The National PCI Registry
Lessons learned From The National PCI Registry w a v e On Behalf of The Publication Committee of the National PCI Registry Objectives & Anticipated Achievements To determine the epidemiology of patients
More informationJournal of the American College of Cardiology Vol. 38, No. 2, by the American College of Cardiology ISSN /01/$20.
Journal of the American College of Cardiology Vol. 38, No. 2, 2001 2001 by the American College of Cardiology ISSN 0735-1097/01/$20.00 Published by Elsevier Science Inc. PII S0735-1097(01)01407-3 Time
More informationRole of platelet glycoprotein IIb/IIIa inhibitors in rescue percutaneous coronary interventions
Role of platelet glycoprotein IIb/IIIa inhibitors in rescue percutaneous coronary interventions Anna Sonia Petronio, Marco De Carlo, Roberta Rossini, Giovanni Amoroso, Ugo Limbruno, Nicola Ciabatti, Caterina
More informationCLINICAL CONSEQUENCES OF THE
CLINICAL CONSEQUENCES OF THE FAME STUDY TCT ASIA Seoul, Korea, april 26 th, 2012 Nico H. J. Pijls, MD, PhD Catharina Hospital, Eindhoven, The Netherlands GUIDELINES ESC SEPTEMBER 2010 FFR UPGRADED TO LEVEL
More informationCoronary Interventions Indications, Treatment Options and Outcomes
Coronary Interventions Indications, Treatment Options and Outcomes A talk should be like a woman s skirt long enough to cover the subject, but short enough to keep it interesting. Coronary anatomy Physiology
More informationSafety of Single- Versus Multi-vessel Angioplasty for Patients with AMI and Multi-vessel CAD
Safety of Single- Versus Multi-vessel Angioplasty for Patients with AMI and Multi-vessel CAD Mun K. Hong, MD Associate Professor of Medicine Director, Cardiovascular Intervention and Research Weill Cornell
More informationOriginal Article. Rogério Sarmento Leite, Ana Maria Krepsky, Carlos A.M. Gottschall. Porto Alegre, RS - Brazil
Arq Bras Cardiol Original Article Leite et al Effectiveness of Primary Angioplasty in the Treatment of Acute Myocardial Infarction. Analysis of In-hospital and Late Outcomes in 135 Consecutive Cases Rogério
More informationAre Asian Patients Different? - Updates Of Biomatrix Experience In Regional Settings: BEACON II (3 Yr F up) &
Are Asian Patients Different? - Updates Of Biomatrix Experience In Regional Settings: BEACON II (3 Yr F up) & Biomatrix TM Single Center Experience (Indonesia)(Final 5 Yr F up) T. Santoso University of
More informationTarget vessel only revascularization versus complet revascularization in non culprit lesions in acute myocardial infarction treated by primary PCI
Target vessel only revascularization versus complet revascularization in non culprit lesions in acute myocardial infarction treated by primary PCI Gamal Abdelhady, Emad Mahmoud Department of interventional
More informationSTEMI: Evolving Early Therapies of Myocardial Ischemia/Reperfusion Injury.
STEMI: Evolving Early Therapies of Myocardial Ischemia/Reperfusion Injury. Borja Ibanez, MD PhD FESC. - Centro Nacional de Investigaciones Cardiovasculares Carlos III (CNIC). - Hospital Clínico San Carlos.
More informationPrimary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials
Articles Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials Ellen C Keeley, Judith A Boura, Cindy L Grines Summary
More informationOBJECTIVES BACKGROUND METHODS RESULTS CONCLUSIONS by the American College of Cardiology ISSN /00/$20.00
Journal of the American College of Cardiology Vol. 36, No. 3, Suppl A 2000 by the American College of Cardiology ISSN 0735-1097/00/$20.00 Published by Elsevier Science Inc. PII S0735-1097(00)00888-3 Cardiogenic
More informationEffect of upstream clopidogrel treatment in patients with ST-segment elevation myocardial infarction undergoing primary PCI
Effect of upstream clopidogrel treatment in patients with ST-segment elevation myocardial infarction undergoing primary PCI Dr Sasha Koul, MD Dept of Cardiology, Lund University Hospital, Lund, Sweden
More informationPROMUS Element Experience In AMC
Promus Element Luncheon Symposium: PROMUS Element Experience In AMC Jung-Min Ahn, MD. University of Ulsan College of Medicine, Heart Institute, Asan Medical Center, Seoul, Korea PROMUS Element Clinical
More informationChapter 3. Departments of a Cardiology and b Medical Statistics, Leiden University Medical Center, Leiden, The Netherlands; c
Chapter 3 Incidence, patient s characteristics and predictors of aborted myocardial infarction in patients undergoing primary PCI: prospective study comparing pre- and in-hospital abciximab pretreatment
More informationIs it safe to discharge patients 24 hours after uncomplicated successful primary percutaneous coronary intervention
Is it safe to discharge patients 24 hours after uncomplicated successful primary percutaneous coronary intervention DA Jones, J Howard, S Gallagher, KS Rathod, A Jain, S Mohiddin, C Knight, A Mathur, EJ
More informationImpact of Thromboaspiration during Primary PCI on infarcted segmental myocardial function: a Tissue Doppler imaging evaluation. EXPIRA Trial substudy.
Impact of Thromboaspiration during Primary PCI on infarcted segmental myocardial function: a Tissue Doppler imaging evaluation. EXPIRA Trial substudy. GENNARO SARDELLA, MD, FACC,FESC; MASSIMO MANCONE,
More informationThe Window for Fibrinolysis. Frans Van de Werf, MD, PhD Leuven, Belgium
The Window for Fibrinolysis Frans Van de Werf, MD, PhD Leuven, Belgium ESC STEMI Guidelines : December 2008 Reperfusion Therapy: Fibrinolytic Therapy Recommendations Class LOE In the absence of contraindications
More informationKomplexe Koronarintervention heute: Von Syntax zu bioresorbierbaren Stents
Komplexe Koronarintervention heute: Von Syntax zu bioresorbierbaren Stents Prof. Dr. med. Julinda Mehilli Medizinische Klinik und Poliklinik I Klinikum der Universität München Campus Großhadern Key Factors
More informationInter-regional differences and outcome in unstable angina
European Heart Journal (2000) 21, 1433 1439 doi:10.1053/euhj.1999.1983, available online at http://www.idealibrary.com on Inter-regional differences and outcome in unstable angina Analysis of the International
More information